The association among negative life events, alexithymia, and depressive symptoms in a psychosomatic outpatient sample.
Alexithymia
Depression
Negative life events
Stepwise regression analysis
Journal
BMC psychiatry
ISSN: 1471-244X
Titre abrégé: BMC Psychiatry
Pays: England
ID NLM: 100968559
Informations de publication
Date de publication:
18 Jun 2024
18 Jun 2024
Historique:
received:
30
12
2023
accepted:
09
06
2024
medline:
19
6
2024
pubmed:
19
6
2024
entrez:
18
6
2024
Statut:
epublish
Résumé
Depression is a life-threatening mental health problem. Various factors have been demonstrated to be associated with depressive symptoms, including negative life events (NLEs) and alexithymia. A retrospective study was conducted to investigate the relationship among negative life events, alexithymia, and depression symptoms in a psychosomatic outpatient sample in China. A total of 2747 outpatients (aged 18 - 65) were included in this investigation. The Life Events Scale (LES), Toronto alexithymia scale (TAS-26), and 9-item Patient Health Questionnaire (PHQ-9) were used to assess NLEs, alexithymia, and depressive symptoms, respectively. A stepwise regression analysis model was established to investigate the relationship among alexithymia, NLEs, and depressive symptoms. Overall, 67.0% of the patient sample had a PHQ-9 score of 10 or higher. The stepwise regression analysis model showed a well-fitted model, in which NLEs and alexithymia explain a total of 34.2% of the variance of depressive symptoms in these participants. NLEs (β = 0.256, p < 0.001) and dimensions of alexithymia (difficult describing feelings (β = 0.192, p < 0.001) and identifying feelings (β = 0.308, p < 0.001)) were positively correlated with symptoms of depression. Previous studies have confirmed the correlation between NLEs and depression, alexithymia and depression, respectively. In our study, we used a stepwise regression model to explain the relationship among those variables simultaneously, and found that NLEs and alexithymia could function as predictors of depressive symptoms. Based on this discovery, alexithymia-focused treatment strategies could be alternative in depressive patients with alexithymia, but this remains to be verified in the future.
Sections du résumé
BACKGROUND
BACKGROUND
Depression is a life-threatening mental health problem. Various factors have been demonstrated to be associated with depressive symptoms, including negative life events (NLEs) and alexithymia. A retrospective study was conducted to investigate the relationship among negative life events, alexithymia, and depression symptoms in a psychosomatic outpatient sample in China.
METHODS
METHODS
A total of 2747 outpatients (aged 18 - 65) were included in this investigation. The Life Events Scale (LES), Toronto alexithymia scale (TAS-26), and 9-item Patient Health Questionnaire (PHQ-9) were used to assess NLEs, alexithymia, and depressive symptoms, respectively. A stepwise regression analysis model was established to investigate the relationship among alexithymia, NLEs, and depressive symptoms.
RESULTS
RESULTS
Overall, 67.0% of the patient sample had a PHQ-9 score of 10 or higher. The stepwise regression analysis model showed a well-fitted model, in which NLEs and alexithymia explain a total of 34.2% of the variance of depressive symptoms in these participants. NLEs (β = 0.256, p < 0.001) and dimensions of alexithymia (difficult describing feelings (β = 0.192, p < 0.001) and identifying feelings (β = 0.308, p < 0.001)) were positively correlated with symptoms of depression.
CONCLUSIONS
CONCLUSIONS
Previous studies have confirmed the correlation between NLEs and depression, alexithymia and depression, respectively. In our study, we used a stepwise regression model to explain the relationship among those variables simultaneously, and found that NLEs and alexithymia could function as predictors of depressive symptoms. Based on this discovery, alexithymia-focused treatment strategies could be alternative in depressive patients with alexithymia, but this remains to be verified in the future.
Identifiants
pubmed: 38890601
doi: 10.1186/s12888-024-05902-0
pii: 10.1186/s12888-024-05902-0
doi:
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Pagination
451Informations de copyright
© 2024. The Author(s).
Références
Reynolds CFR, Patel V. Screening for depression: the global mental health context. World Psychiatry. 2017;16(3):316–7. https://doi.org/10.1002/wps.20459 .
doi: 10.1002/wps.20459
pubmed: 28941110
pmcid: 5608832
Ferrari AJ, Somerville AJ, Baxter AJ, Norman R, Patten SB, Vos T, Whiteford HA. Global variation in the prevalence and incidence of major depressive disorder: a systematic review of the epidemiological literature. Psychol Med. 2013;43(3):471–81. https://doi.org/10.1017/s0033291712001511 .
doi: 10.1017/s0033291712001511
pubmed: 22831756
Cuijpers P, Pineda BS, Quero S, Karyotaki E, Struijs SY, Figueroa CA, Llamas JA, Furukawa TA, Muñoz RF. Psychological interventions to prevent the onset of depressive disorders: a meta-analysis of randomized controlled trials. Clin Psychol Rev. 2021;83:101955. https://doi.org/10.1016/j.cpr.2020.101955 .
doi: 10.1016/j.cpr.2020.101955
pubmed: 33333441
Cipriani A, Furukawa TA, Salanti G, Chaimani A, Atkinson LZ, Ogawa Y, Leucht S, Ruhe HG, Turner EH, Higgins JPT, et al. Comparative efficacy and acceptability of 21 antidepressant drugs for the acute treatment of adults with major depressive disorder: a systematic review and network meta-analysis. Lancet (London England). 2018;391(10128):1357–66. https://doi.org/10.1016/s0140-6736(17)32802-7 .
doi: 10.1016/s0140-6736(17)32802-7
pubmed: 29477251
pmcid: 5889788
MacQueen GM, Campbell S, McEwen BS, Macdonald K, Amano S, Joffe RT, Nahmias C, Young LT. Course of illness, hippocampal function, and hippocampal volume in major depression. Proc Natl Acad Sci USA. 2003;100(3):1387–92. https://doi.org/10.1073/pnas.0337481100 .
doi: 10.1073/pnas.0337481100
pubmed: 12552118
pmcid: 298782
Schmaal L, Veltman DJ, van Erp TG, Sämann PG, Frodl T, Jahanshad N, Loehrer E, Tiemeier H, Hofman A, Niessen WJ, et al. Subcortical brain alterations in major depressive disorder: findings from the ENIGMA Major Depressive disorder working group. Mol Psychiatry. 2016;21(6):806–12. https://doi.org/10.1038/mp.2015.69 .
doi: 10.1038/mp.2015.69
pubmed: 26122586
Thapar A, Eyre O, Patel V, Brent D. Depression in young people. Lancet. 2022;400(10352):617–31. https://doi.org/10.1016/S0140-6736(22)01012-1 .
doi: 10.1016/S0140-6736(22)01012-1
pubmed: 35940184
Herrman H, Patel V, Kieling C, Berk M, Buchweitz C, Cuijpers P, Furukawa TA, Kessler RC, Kohrt BA, Maj M, et al. Time for united action on depression: a Lancet-World Psychiatric Association Commission. Lancet. 2022;399(10328):957–1022. https://doi.org/10.1016/s0140-6736(21)02141-3 .
doi: 10.1016/s0140-6736(21)02141-3
pubmed: 35180424
Monroe SM, Simons AD. Diathesis-stress theories in the context of life stress research: implications for the depressive disorders. Psychol Bull. 1991;110(3):406–25. https://doi.org/10.1037/0033-2909.110.3.406 .
doi: 10.1037/0033-2909.110.3.406
pubmed: 1758917
Sun XJ, Niu GF, You ZQ, Zhou ZK, Tang Y. Gender, negative life events and coping on different stages of depression severity: a cross-sectional study among Chinese university students. J Affect Disord. 2017;209:177–81. https://doi.org/10.1016/j.jad.2016.11.025 .
doi: 10.1016/j.jad.2016.11.025
pubmed: 27923194
Paykel ES, Myers JK, Dienelt MN, Klerman GL, Lindenthal JJ, Pepper MP. Life events and depression. A controlled study. Arch Gen Psychiatry. 1969;21(6):753–60. https://doi.org/10.1001/archpsyc.1969.01740240113014 .
doi: 10.1001/archpsyc.1969.01740240113014
pubmed: 5389659
Wardenaar KJ, van Veen T, Giltay EJ, Zitman FG, Penninx BW. The use of symptom dimensions to investigate the longitudinal effects of life events on depressive and anxiety symptomatology. J Affect Disord. 2014;156:126–33. https://doi.org/10.1016/j.jad.2013.12.004 .
doi: 10.1016/j.jad.2013.12.004
pubmed: 24388686
Zuo B, Zhang X, Wen FF, Zhao Y. The influence of stressful life events on depression among Chinese university students: multiple mediating roles of fatalism and core self-evaluations. J Affect Disord. 2020;260:84–90. https://doi.org/10.1016/j.jad.2019.08.083 .
doi: 10.1016/j.jad.2019.08.083
pubmed: 31493644
Sifneos PE. The prevalence of ‘alexithymic’ characteristics in psychosomatic patients. Psychother Psychosom. 1973;22(2):255–62. https://doi.org/10.1159/000286529 .
doi: 10.1159/000286529
pubmed: 4770536
Martin JB, Pihl RO. The stress-alexithymia hypothesis: theorectical and empirical considerations. Psychother Psychosom. 1985;43(4):169–76. https://doi.org/10.1159/000287876 .
doi: 10.1159/000287876
pubmed: 4034888
de Timary P, Roy E, Luminet O, Fillée C, Mikolajczak M. Relationship between alexithymia, alexithymia factors and salivary cortisol in men exposed to a social stress test. Psychoneuroendocrinology. 2008;33(8):1160–4. https://doi.org/10.1016/j.psyneuen.2008.06.005 .
doi: 10.1016/j.psyneuen.2008.06.005
pubmed: 18674866
Nekouei ZK, Doost HT, Yousefy A, Manshaee G, Sadeghei M. The relationship of Alexithymia with anxiety-depression-stress, quality of life, and social support in Coronary Heart Disease (a psychological model). J Educ Health Promotion. 2014;3:68. https://doi.org/10.4103/2277-9531.134816 .
doi: 10.4103/2277-9531.134816
Ogrodniczuk JS, Piper WE, Joyce AS. Alexithymia as a predictor of residual symptoms in depressed patients who respond to short-term psychotherapy. Am J Psychother. 2004;58(2):150–61. https://doi.org/10.1176/appi.psychotherapy.2004.58.2.150 .
doi: 10.1176/appi.psychotherapy.2004.58.2.150
pubmed: 15373278
Honkalampi K, Hintikka J, Tanskanen A, Lehtonen J, Viinamäki H. Depression is strongly associated with alexithymia in the general population. J Psychosom Res. 2000;48(1):99–104. https://doi.org/10.1016/s0022-3999(99)00083-5 .
doi: 10.1016/s0022-3999(99)00083-5
pubmed: 10750635
Marchesi C, Bertoni S, Cantoni A, Maggini C. Is alexithymia a personality trait increasing the risk of depression? A prospective study evaluating alexithymia before, during and after a depressive episode. Psychol Med. 2008;38(12):1717–22. https://doi.org/10.1017/s0033291708003073 .
doi: 10.1017/s0033291708003073
pubmed: 18366825
Ashley L, O’Connor DB, Jones F. Effects of Emotional Disclosure in caregivers: moderating role of Alexithymia. J Stress Health. 2011;27(5):376–87. https://doi.org/10.1002/smi.1388 .
doi: 10.1002/smi.1388
Yang D, Zhang Y. Life event scale (LES). Rat Scales Mental Health. 1999;25:29.
Yang J, Ke S, Qiao Z, Yang X, Qiu X, Song X, Zhao E, Zhou J, Zhao M, Yang Y, et al. Interactions between glycogen synthase Kinase-3β gene polymorphisms, Negative Life Events, and susceptibility to major depressive disorder in a Chinese Population. Front Psychiatry. 2021;11:503477. https://doi.org/10.3389/fpsyt.2020.503477 .
doi: 10.3389/fpsyt.2020.503477
pubmed: 33658947
pmcid: 7917206
Xiong N, Liu Q, Lv X, Leonhart R, Tian H, Wei J, Zhang K, Zhu G, Chen Q, Wang G, et al. Demographic and psychosocial variables could predict the occurrence of major depressive disorder, but not the severity of Depression in patients with first-episode major depressive disorder in China. J Affect Disord. 2020;274:103–11. https://doi.org/10.1016/j.jad.2020.05.065 .
doi: 10.1016/j.jad.2020.05.065
pubmed: 32469792
Kroenke K, Spitzer RL. The PHQ-9: a new depression diagnostic and severity measure. J Psychiatric Annals. 2002;32(9):509–15.
doi: 10.3928/0048-5713-20020901-06
Gilbody S, Richards D, Brealey S, Hewitt C. Screening for Depression in Medical Settings with the Patient Health Questionnaire (PHQ): a diagnostic Meta-analysis. J Gen Intern Med. 2007;22(11):1596–602. https://doi.org/10.1007/s11606-007-0333-y .
doi: 10.1007/s11606-007-0333-y
pubmed: 17874169
pmcid: 2219806
Zimmerman M. Using the 9-Item Patient Health Questionnaire to screen for and Monitor Depression. JAMA. 2019;322(21):2125–6. https://doi.org/10.1001/jama.2019.15883 .
doi: 10.1001/jama.2019.15883
pubmed: 31626276
Xiong N, Fritzsche K, Wei J, Hong X, Leonhart R, Zhao X, Zhang L, Zhu L, Tian G, Nolte S, et al. Validation of patient health questionnaire (PHQ) for major depression in Chinese outpatients with multiple somatic symptoms: a multicenter cross-sectional study. J Affect Disord. 2015;174:636–43. https://doi.org/10.1016/j.jad.2014.12.042 .
doi: 10.1016/j.jad.2014.12.042
pubmed: 25576931
Taylor GJ, Ryan D, Bagby M. Toward the development of a New Self-Report Alexithymia Scale. Psychother Psychosom. 2010;44(4):191–9. https://doi.org/10.1159/000287912 .
doi: 10.1159/000287912
Taylor GJ, Bagby RM, Ryan DP, Parker JD, Doody KF, Keefe P. Criterion validity of the Toronto Alexithymia Scale. Psychosom Med. 1988;50(5):500–9. https://doi.org/10.1097/00006842-198809000-00006 .
doi: 10.1097/00006842-198809000-00006
pubmed: 3186893
Taylor GJ, Bagby M, Parker JDA. The revised Toronto Alexithymia Scale: some reliability, validity, and normative data. Psychother Psychosom. 2010;57(1–2):34–41. https://doi.org/10.1159/000288571 .
doi: 10.1159/000288571
Huang Y, Wang Y, Wang H, Liu Z, Yu X, Yan J, Yu Y, Kou C, Xu X, Lu J, et al. Prevalence of mental disorders in China: a cross-sectional epidemiological study. Lancet Psychiatry. 2019;6(3):211–24. https://doi.org/10.1016/s2215-0366(18)30511-x .
doi: 10.1016/s2215-0366(18)30511-x
pubmed: 30792114
Taquet M, Geddes JR, Husain M, Luciano S, Harrison PJ. 6-month neurological and psychiatric outcomes in 236 379 survivors of COVID-19: a retrospective cohort study using electronic health records. Lancet Psychiatry. 2021;8(5):416–27. https://doi.org/10.1016/s2215-0366(21)00084-5 .
doi: 10.1016/s2215-0366(21)00084-5
pubmed: 33836148
pmcid: 8023694
Dragioti E, Li H, Tsitsas G, Lee KH, Choi J, Kim J, Choi YJ, Tsamakis K, Estradé A, Agorastos A, et al. A large-scale meta-analytic atlas of mental health problems prevalence during the COVID-19 early pandemic. J Med Virol. 2022;94(5):1935–49. https://doi.org/10.1002/jmv.27549 .
doi: 10.1002/jmv.27549
pubmed: 34958144
pmcid: 9015528
Wu T, Jia X, Shi H, Niu J, Yin X, Xie J, Wang X. Prevalence of mental health problems during the COVID-19 pandemic: a systematic review and meta-analysis. J Affect Disord. 2021;281:91–8. https://doi.org/10.1016/j.jad.2020.11.117 .
doi: 10.1016/j.jad.2020.11.117
pubmed: 33310451
Ramirez D, Rufino KA, Rech ME, Poa E, Patriquin MA. Increased symptom severity in adults and adolescents admitting to an inpatient psychiatric hospital during the COVID-19 pandemic. Psychiatry Res. 2022;316:114758. https://doi.org/10.1016/j.psychres.2022.114758 .
doi: 10.1016/j.psychres.2022.114758
pubmed: 35944372
pmcid: 9338827
Liu Y, Deng L, Zhang R, Pu Y, Yan J, Wang H. Longitudinal relationship between quality of life and negative life events among adolescents during COVID-19 pandemic: a cross-lagged panel analysis. Environ Health Prev Med. 2023;28:67. https://doi.org/10.1265/ehpm.22-00284 .
doi: 10.1265/ehpm.22-00284
pubmed: 37914349
pmcid: 10636289
Osimo SA, Aiello M, Gentili C, Ionta S, Cecchetto C. The influence of personality, resilience, and Alexithymia on Mental Health during COVID-19 pandemic. Front Psychol. 2021;12:630751. https://doi.org/10.3389/fpsyg.2021.630751 .
doi: 10.3389/fpsyg.2021.630751
pubmed: 33716896
pmcid: 7943855
Liu L, Liu C, Ke X, Li N. Mediating effect of social support on the association between life events and depression: a cross-sectional study of adolescents in Chongqing China. Med (Baltim). 2020;99(51):e22627. https://doi.org/10.1097/MD.0000000000022627 .
doi: 10.1097/MD.0000000000022627
Horesh N, Klomek AB, Apter A. Stressful life events and major depressive disorders. Psychiatry Res. 2008;160(2):192–9. https://doi.org/10.1016/j.psychres.2007.06.008 .
doi: 10.1016/j.psychres.2007.06.008
pubmed: 18582951
Mundt C, Reck C, Backenstrass M, Kronmüller K, Fiedler P. Reconfirming the role of life events for the timing of depressive episodes. A two-year prospective follow-up study. J Affect Disord. 2000;59(1):23–30. https://doi.org/10.1016/s0165-0327(99)00127-5 .
doi: 10.1016/s0165-0327(99)00127-5
pubmed: 10814767
Laglaoui Bakhiyi C, Jaussent I, Beziat S, Cohen R, Genty C, Kahn JP, Leboyer M, Le Vaou P, Guillaume S, Courtet P. Positive and negative life events and reasons for living modulate suicidal ideation in a sample of patients with history of suicide attempts. J Psychiatr Res. 2017;88:64–71. https://doi.org/10.1016/j.jpsychires.2016.12.022 .
doi: 10.1016/j.jpsychires.2016.12.022
pubmed: 28088052
Cuijpers P, Smit F, Unger F, Stikkelbroek Y, Ten Have M, de Graaf R. The disease burden of childhood adversities in adults: a population-based study. Child Abuse Negl. 2011;35(11):937–45. https://doi.org/10.1016/j.chiabu.2011.06.005 .
doi: 10.1016/j.chiabu.2011.06.005
pubmed: 22099144
Charbonneau AM, Mezulis AH, Hyde JS. Stress and emotional reactivity as explanations for gender differences in adolescents’ depressive symptoms. J Youth Adolesc. 2009;38(8):1050–8. https://doi.org/10.1007/s10964-009-9398-8 .
doi: 10.1007/s10964-009-9398-8
pubmed: 19636770
Li R, Kajanoja J, Karlsson L, Karlsson H, Karukivi M. Sex-specific role of alexithymia in associations between parental bonding and mental health: a moderated mediation model. J Clin Psychol. 2023;79(1):126–42. https://doi.org/10.1002/jclp.23372 .
doi: 10.1002/jclp.23372
pubmed: 35521753
Radetzki PA, Wrath AJ, Le T, Adams GC. Alexithymia is a mediating factor in the relationship between adult attachment and severity of depression and social anxiety. J Affect Disord. 2021;295:846–55. https://doi.org/10.1016/j.jad.2021.08.057 .
doi: 10.1016/j.jad.2021.08.057
pubmed: 34706455
Motan I, Gençöz T. The relationship between the dimensions of alexithymia and the intensity of depression and anxiety. Turk Psikiyatri Dergisi = Turkish J Psychiatry. 2007;18(4):333–43.
Li S, Zhang B, Guo Y, Zhang J. The association between alexithymia as assessed by the 20-item Toronto Alexithymia Scale and depression: a meta-analysis. Psychiatry Res. 2015;227(1):1–9. https://doi.org/10.1016/j.psychres.2015.02.006 .
doi: 10.1016/j.psychres.2015.02.006
pubmed: 25769520
Wiebe A, Kersting A, Suslow T. Deployment of attention to emotional pictures varies as a function of externally-oriented thinking: an eye tracking investigation. J Behav Ther Exp Psychiatry. 2017;55:1–5. https://doi.org/10.1016/j.jbtep.2016.11.001 .
doi: 10.1016/j.jbtep.2016.11.001
pubmed: 27838297
Bagby RM, Ayearst LE, Morariu RA, Watters C, Taylor GJ. The internet administration version of the 20-item Toronto alexithymia scale. Psychol Assess. 2014;26(1):16–22. https://doi.org/10.1037/a0034316 .
doi: 10.1037/a0034316
pubmed: 24015859
de Tychey C, Garnier S, Lighezzolo-Alnot J, Claudon P, Rebourg-Roesler C. An accumulation of negative life events and the construction of alexithymia: a longitudinal and clinical approach. J Pers Assess. 2010;92(3):189–206. https://doi.org/10.1080/00223891003670125 .
doi: 10.1080/00223891003670125
pubmed: 20408019
Panayiotou G, Leonidou C, Constantinou E, Hart J, Rinehart KL, Sy JT, Björgvinsson T. Do alexithymic individuals avoid their feelings? Experiential avoidance mediates the association between alexithymia, psychosomatic, and depressive symptoms in a community and a clinical sample. Compr Psychiatry. 2015;56:206–16. https://doi.org/10.1016/j.comppsych.2014.09.006 .
doi: 10.1016/j.comppsych.2014.09.006
pubmed: 25263517
Berenbaum H. Childhood abuse, alexithymia and personality disorder. J Psychosom Res. 1996;41(6):585–95. https://doi.org/10.1016/s0022-3999(96)00225-5 .
doi: 10.1016/s0022-3999(96)00225-5
pubmed: 9032722
Hébert M, Boisjoli C, Blais M, Oussaïd E. Alexithymia as a mediator of the relationship between child sexual abuse and psychological distress in adolescence: a short-term longitudinal study. Psychiatry Res. 2018;260:468–72. https://doi.org/10.1016/j.psychres.2017.12.022 .
doi: 10.1016/j.psychres.2017.12.022
pubmed: 29274605
pmcid: 5770211
Salminen JK, Saarijärvi S, Aäirelä E, Tamminen T. Alexithymia–state or trait? One-year follow-up study of general hospital psychiatric consultation out-patients. J Psychosom Res. 1994;38(7):681–5. https://doi.org/10.1016/0022-3999(94)90020-5 .
doi: 10.1016/0022-3999(94)90020-5
pubmed: 7877122
Norman H, Marzano L, Coulson M, Oskis A. Effects of mindfulness-based interventions on alexithymia: a systematic review. Evid Based Ment Health. 2019;22(1):36–43. https://doi.org/10.1136/ebmental-2018-300029 .
doi: 10.1136/ebmental-2018-300029
pubmed: 30077988
pmcid: 10270453
Porcelli P, Tulipani C, Di Micco C, Spedicato MR, Maiello E. Temporal stability of alexithymia in cancer patients following a psychological intervention. J Clin Psychol. 2011;67(12):1177–87. https://doi.org/10.1002/jclp.20839 .
doi: 10.1002/jclp.20839
pubmed: 22052601
Salles BM, Maturana de Souza W, Dos Santos VA, Mograbi DC. Effects of DBT-based interventions on alexithymia: a systematic review. Cogn Behav Ther. 2023;52(2):110–31. https://doi.org/10.1080/16506073.2022.2117734 .
doi: 10.1080/16506073.2022.2117734
pubmed: 36426727